Literature DB >> 34327721

dCas9 techniques for transcriptional repression in mammalian cells: Progress, applications and challenges.

Yuanyuan Li1, Li-Quan Zhou1.   

Abstract

Innovative loss-of-function techniques developed in recent years have made it much easier to target specific genomic loci at transcriptional levels. CRISPR interference (CRISPRi) has been proven to be the most effective and specific tool to knock down any gene of interest in mammalian cells. The catalytically deactivated Cas9 (dCas9) can be fused with transcription repressors to downregulate gene expression specified by sgRNA complementary to target genomic sequence. Although CRISPRi has huge potential for gene knockdown, there is still a lack of systematic guidelines for efficient and widespread use. Here we describe the working mechanism and development of CRISPRi, designing principles of sgRNA, delivery methods and applications in mammalian cells in detail. Finally, we propose possible solutions and future directions with regard to current challenges.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  CRISPR interference; dCas9; sgRNA; transcriptional repression; transcriptional repressor

Year:  2021        PMID: 34327721     DOI: 10.1002/bies.202100086

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  1 in total

1.  Paired guide RNA CRISPR-Cas9 screening for protein-coding genes and lncRNAs involved in transdifferentiation of human B-cells to macrophages.

Authors:  Carme Arnan; Sebastian Ullrich; Carlos Pulido-Quetglas; Ramil Nurtdinov; Alexandre Esteban; Joan Blanco-Fernandez; Estel Aparicio-Prat; Rory Johnson; Sílvia Pérez-Lluch; Roderic Guigó
Journal:  BMC Genomics       Date:  2022-05-26       Impact factor: 4.547

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.